Reports Of Patients’ Deaths Linked To Heart Devices Lurk Below Radar
Another KHN scoop on how the FDA has been hiding reports of bad outcomes with medical devices, in this case, ones for heart disease.
Read more...Another KHN scoop on how the FDA has been hiding reports of bad outcomes with medical devices, in this case, ones for heart disease.
Read more...Heatlh care CEOs are a prime example of executive feather-bedding.
Read more...Private equity is moving in a big way into elder and child care services in the UK. Patients and parents beware.
Read more...Sanders commissioned a GAO report on how high student debt levels and lousy wages translate into poor economic prospects for young people.
Read more...The IMF is backing a tax reform bill in Ecuador that will enable capital flight and further austerity.
Read more...How health insurers discriminate against rural communities.
Read more...While you were distracted by impeachment theatrics, Trump creates more obstacles to keeping Social Security disability benefits
Read more...Virginia Supreme Court allows Koch influence to remain undisclosed; the decision has yet to attract much media attention.
Read more...California governor Newsom’s rejection of PG&E bankruptcy plan forces the company to present an alternative before Tuesday.
Read more...Argentina attempts to push fracking, despite its poor economic prospects – even worse than the industry’s lossmaking record in the US.
Read more...In her new book, Don’t Be Evil, Rana Foroohar explores how companies like Google and their tech brethren stampede over all of us.
Read more...On the deliberately vicious use of supposedly use of less lethal weapons.
Read more...British officials dodged invitations to exclude the NHS from a US-UK trade deal. Not surprising, given how much public money already goes to the US healthcare industry.
Read more...Between 1920 and 1992, English elites concealed 20-32% of their wealth. Accounting for hidden wealth eliminates one-third of the observed decline of top 10% wealth share over the past century.
Read more...A takedown of the pharmaceutical industry’s assertion that it need to price gouge so it can invest in R&D. Profits go almost entirely to various forms of looting.
Read more...